Sign in
Not yet recruitingPhase 3

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

Key facts

Who runs it
Central Hospital, Nancy, France
Where
France25 sites in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 3
People taking part
4,336 people, planned
Started
Jun 2026
Expected to end
Jul 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Epinephrine 0.5 mg intravenous bolus
  • Epinephrine 1 mg intravenous bolus
Record updated
2 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Male or female, aged ≥18 years. Out-of-hospital cardiac arrest for which resuscitation is decided by the SMUR team
  • Medical Out-of-hospital cardiac arrest. Affiliated with or beneficiary of a social security plan

Who cannot take part

  • Non-medical Out-of-hospital cardiac arrest (traumatic, drownings, electrocution, asphyxia, overdose, unknown cause)
  • Out-of-hospital cardiac arrest without advanced life support (Do Not Attempt Resuscitation order, body finding, the decision not to attempt advanced life support is at the physician's discretion); Pregnant women, birthing or breastfeeding mothers; Adults under legal protection measure (such as guardianship, conservatorship); Individuals deprived of liberty due to judicial or administrative decision

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.

The 2 groups in the trial

  • Epinephrine 0.5 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary ResuscitationTreatment being tested

    Treatment: Epinephrine 0.5 mg intravenous bolus

  • Epinephrine 1 mg IV bolus every 3-5 minutes during Cardio-Pulmonary ResuscitationExisting treatment, for comparison

    Epinephrine 1 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation

    Treatment: Epinephrine 1 mg intravenous bolus

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome: A Multicenter Randomized and Double-blind Trial.
Record updated
2 March 2026